Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Diamyd Medical enters agreement for phase II study of diabetes vaccine candidate

Oct. 16, 2019

Competition between HuR and miR-330 modulates STAT3 expression promoting muscle wasting in cachexia

Oct. 16, 2019

Auris reports phase Ib interim data on AM-201 for antipsychotic-induced weight gain and somnolence

Oct. 14, 2019

New insulin receptor partial agonists discovered at Merck & Co.

Oct. 14, 2019

Rubius initiates first-in-human study of RTX-135 for phenylketonuria

Oct. 10, 2019

FDA approves PF-708 for osteoporosis

Oct. 10, 2019

Mithra initiates phase III E4 Comfort clinical program for Donesta

Oct. 10, 2019

New mouse model of diabetic cystopathy described

Oct. 9, 2019

Enrollment underway in phase I/II study of CTNS-RD-04 stem cell gene therapy for cystinosis

Oct. 8, 2019

Novel transgenerational mouse model of insulin resistance

Oct. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...